A detailed history of Matrix Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Matrix Trust CO holds 438 shares of LLY stock, worth $274,034. This represents 0.05% of its overall portfolio holdings.

Number of Shares
438
Previous 267 64.04%
Holding current value
$274,034
Previous $221,000 54.3%
% of portfolio
0.05%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 11, 2025

BUY
$713.71 - $898.95 $122,044 - $153,720
171 Added 64.04%
438 $341,000
Q1 2025

Apr 10, 2025

BUY
$725.72 - $929.72 $39,914 - $51,134
55 Added 25.94%
267 $221,000
Q4 2024

Jan 10, 2025

BUY
$727.2 - $932.06 $154,166 - $197,596
212 New
212 $164,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $594B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Matrix Trust CO Portfolio

Follow Matrix Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Trust CO with notifications on news.